SOFIA (Bulgaria), September 2 (SeeNews) -Â Bulgarian drug maker Sopharma [BUL:3JR] said its consolidated net profit, excluding minority interest, fell to 20.6 million levs ($12.4 million/10.5 million euro) in the first half of 2020, compared to a 22.6Â million levs profit a year earlier, despite an increase in revenue.Â